NVIDIA (NVDA) had technical 'breakout', stock seen headed to over $600

Go back to NVIDIA (NVDA) had technical 'breakout', stock seen headed to over $600

NVIDIA (NVDA) healthcare vertical already a $1bn+ business - JPMorgan

January 9, 2024 2:10 PM EST

JPMorgan's Harian Sur maintained an Overweight rating on NVIDIA (NASDAQ: NVDA) in a note Tuesday, saying the company's healthcare vertical is already a $1 billion+ business.

The company's healthcare business is driven by the increasing computational demand for AIdrug discovery, genomics, patient... More